The physical removal of soft thrombus from blood arteries is referred to as thrombectomy. A thrombectomy device is simple to operate and reliably opens blood vessels, allowing blood clots to be removed. By increasing the rate of procedural recanalization, thrombectomy devices can improve long-term neurological results. The clot relaxes and partially dissolves as recanalization begins, indicating clinical recovery. Thrombectomy devices can be utilized in individuals who are likely to be ineffective or inappropriate for pharmacological treatments such as thrombolysis, such as those who have just undergone cardiovascular surgery, or those who are on oral anticoagulants.
Over the projected period, the worldwide thrombectomy devices market is expected to rise due to an increase in new product releases and regulatory approvals for thrombectomy devices.
Control Medical Technology, for example, reported in January 2021 that the US FDA (Food and Drug Administration) has approved the Control 11F Mechanical Thrombectomy Devices Market, which is designed to remove big blood clots from patients with deep vein thrombosis (DVT). Furthermore, Control Medical Technology reported in May 2020 that the Aspire MAX 7 – 11F Mechanical Thrombectomy platform had been cleared by the US FDA to remove blood clots from peripheral veins. In March 2021, however, Vetex Medical Ltd. announced that the US Food and Drug Administration (FDA) has given the ReVene thrombectomy catheter 510 (K) clearance. ReVene is built using dual-action technology.
Market Opportunity for Thrombectomy Devices in the Global Market
Increasing development of advanced thrombectomy devices, as well as market players' adoption of inorganic expansion methods such as acquisition, partnership, and others, are likely to drive market growth throughout the forecast period. For example, in April 2019, Edwards Lifesciences Corporation purchased CAS Medical Systems, Inc., a medical technology business that specializes in non-invasive brain tissue oxygenation monitoring.
Players to Watch
LeMaitre Vascular, Inc., Boston Scientific Corporation, Control Medical Technology, Edwards Lifesciences Corporation, Johnson & Johnson, Medtronic Plc., Merit Medical Systems, Inc., Stryker Corporation, Terumo Corporation, Penumbra, Inc., Argon Medical Devices, Teleflex Incorporated, and Vetex Medical Ltd. are some of the major players in the global thrombectomy devices market.
0 Comments